Cargando…
Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat v...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486017/ https://www.ncbi.nlm.nih.gov/pubmed/36055577 http://dx.doi.org/10.1016/j.molmet.2022.101588 |
_version_ | 1784792185521045504 |
---|---|
author | Ni, Bin Chen, Shanshan Ryan, Kathleen A. Maitland, Michael L. Farrar, Jared S. Witzenrath, Martin Gubier, Birgitt Serdjebi, Cindy Bertotti, Karine Wang, Rui Salloum, Fadi N. Marino, Luigi Mitchell, Braxton D. Celi, Francesco S. |
author_facet | Ni, Bin Chen, Shanshan Ryan, Kathleen A. Maitland, Michael L. Farrar, Jared S. Witzenrath, Martin Gubier, Birgitt Serdjebi, Cindy Bertotti, Karine Wang, Rui Salloum, Fadi N. Marino, Luigi Mitchell, Braxton D. Celi, Francesco S. |
author_sort | Ni, Bin |
collection | PubMed |
description | Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat vascularization, which is a precondition for the transport of substrate and the dissipation of heat. Angiopoietin-2 is an important driver of vascularization, and its transcription is in part promoted by estrogen signaling. In this study we demonstrate that adipose tissue-specific knock out of Angiopoietin-2 causes a female-specific reduced thermogenic fat differentiation and function, resulting in obesity and impaired glucose tolerance with end-organ features consistent with metabolic syndrome. In humans, angiopoietin-2 levels are higher in females than in males, and are inversely correlated with adiposity and age more strongly in pre-menopause when compared to post-menopause. Collectively, these data indicate a novel and important role for estrogen-mediated Angiopoietin-2 adipose tissue production in the protection against calorie overload in females, and potentially in the development of postmenopausal weight gain. |
format | Online Article Text |
id | pubmed-9486017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94860172022-09-21 Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome Ni, Bin Chen, Shanshan Ryan, Kathleen A. Maitland, Michael L. Farrar, Jared S. Witzenrath, Martin Gubier, Birgitt Serdjebi, Cindy Bertotti, Karine Wang, Rui Salloum, Fadi N. Marino, Luigi Mitchell, Braxton D. Celi, Francesco S. Mol Metab Original Article Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat vascularization, which is a precondition for the transport of substrate and the dissipation of heat. Angiopoietin-2 is an important driver of vascularization, and its transcription is in part promoted by estrogen signaling. In this study we demonstrate that adipose tissue-specific knock out of Angiopoietin-2 causes a female-specific reduced thermogenic fat differentiation and function, resulting in obesity and impaired glucose tolerance with end-organ features consistent with metabolic syndrome. In humans, angiopoietin-2 levels are higher in females than in males, and are inversely correlated with adiposity and age more strongly in pre-menopause when compared to post-menopause. Collectively, these data indicate a novel and important role for estrogen-mediated Angiopoietin-2 adipose tissue production in the protection against calorie overload in females, and potentially in the development of postmenopausal weight gain. Elsevier 2022-08-30 /pmc/articles/PMC9486017/ /pubmed/36055577 http://dx.doi.org/10.1016/j.molmet.2022.101588 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Ni, Bin Chen, Shanshan Ryan, Kathleen A. Maitland, Michael L. Farrar, Jared S. Witzenrath, Martin Gubier, Birgitt Serdjebi, Cindy Bertotti, Karine Wang, Rui Salloum, Fadi N. Marino, Luigi Mitchell, Braxton D. Celi, Francesco S. Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title | Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title_full | Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title_fullStr | Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title_full_unstemmed | Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title_short | Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
title_sort | selective adipocyte loss of angiopoietin-2 prompts female-specific obesity and metabolic syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486017/ https://www.ncbi.nlm.nih.gov/pubmed/36055577 http://dx.doi.org/10.1016/j.molmet.2022.101588 |
work_keys_str_mv | AT nibin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT chenshanshan selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT ryankathleena selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT maitlandmichaell selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT farrarjareds selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT witzenrathmartin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT gubierbirgitt selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT serdjebicindy selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT bertottikarine selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT wangrui selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT salloumfadin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT marinoluigi selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT mitchellbraxtond selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome AT celifrancescos selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome |